Abstract: The present invention relates to a composition for preventing or treating a muscle disorder, which includes a chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1?, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance.

Abstract: A display device includes: a substrate including a display region including a plurality of pixel regions, and a non-display region at a periphery of the display region; a pixel circuit layer including a plurality of circuit elements in the display region; a display element layer including a plurality of light emitting devices in the display region on the pixel circuit layer; and first and second alignment lines in the non-display region, the first and second alignment lines each having a multi-layered structure. Each of the first and second alignment lines includes: a main line in a same layer as at least one electrode in the display element layer; and at least one sub-line electrically connected to the main line, the at least one sub-line in a same layer as at least one electrode in the pixel circuit layer.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: A manual shift lever system may be provided that includes: a shift lever which includes a rod and a stopper formed on the rod; a shift lock unit which limits a movement of the rod; and a control unit which, when a speed of a vehicle is greater than a critical speed of a predetermined gear limits the movement of the rod in a shift direction of the predetermined gear. The shift lock unit includes: at least one shift lock cam part including a main cam, a sub-cam, a shaft which functions as a rotating shaft of the main cam and the sub-cam, and a spring which connects the main cam and the sub-cam; a permanent magnet which is connected to the shift lock cam part; and an electromagnet arranged to have a polarity arrangement opposite to that of the permanent magnet.

Abstract: The present invention relates to a composition for muscle function improvement or exercise ability enhancement, the composition including kirenol, a Siegesbeckia herba extract, or a fraction of the Siegesbeckia herba extract as an active ingredient. Kirenol, the Siegesbeckia herba extract containing kirenol, or the Siegesbeckia herba extract fraction according to the present invention has an excellent effect of increasing muscle mass by increasing the protein expression of p-mTOR, which is a major gene concerned with muscle functions. Also, kirenol, the Siegesbeckia herba extract containing kirenol, or the Siegesbeckia herba extract fraction according to the present invention has an effect of remarkably enhancing exercise ability by increasing the protein expression of PGC-1?, which is a major gene concerned with exercise ability. In addition, the present invention is a natural product, and thus is safe for use without side effects and can be used as a medicine or food.

Abstract: The present disclosure relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the vector, and a method for producing a target protein using the promoter.

Abstract: The present invention relates to an in-situ method for preparing rebaudioside A from sucrose and stevioside by sucrose synthase and glycosyltransferase.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: The present disclosure relates to a method for preparing myo-inositol using myo-inositol monophosphate synthase consisting of an amino acid sequence of SEQ ID NO: 1 and/or myo-inositol monophosphate phosphatase consisting of an amino acid sequence of SEQ ID NO: 3.

Abstract: The present application relates to creamer comprising vegetable lipids, casein, maltose, phosphates, and allulose.

Abstract: A cover window for a display device includes a first film; a second film on the first film; an adhesive layer between the first film and the second film; a coating layer on the second film; and an inner anti-reflective layer between the first film and the coating layer.

Abstract: The present disclosure relates to fructose-6-phosphate-3-epimerase consisting of an amino acid sequence of SEQ ID NO: 1, a nucleic acid encoding the fructose-6-phosphate-3-epimerase, and a transformant comprising the nucleic acid. Additionally, the present disclosure relates to a composition for producing allulose, which comprises the fructose-6-phosphate-3-epimerase of the present disclosure, and a method for producing allulose using the fructose-6-phosphate-3-epimerase of the present disclosure.

Abstract: The present disclosure relates to tagatose-6-phosphate phosphatase consisting of an amino acid sequence of SEQ ID NO: 1, a nucleic acid encoding the tagatose-6-phosphate phosphatase, and a transformant comprising the nucleic acid. Additionally, the present disclosure relates to a composition for producing tagatose, which comprises the tagatose-6-phosphate phosphatase of the present disclosure, and a method for producing tagatose using the tagatose-6-phosphate phosphatase of the present disclosure.

Abstract: An electronic device includes a foldable display device, a supporting member, and a housing. The foldable display device includes at least one folding area and a plurality of non-folding areas. The supporting member is disposed in the non-folding areas to support the foldable display device. The housing includes a body part that contains the foldable display device and the supporting member, and a hinge member that folds or unfolds sections of the body part, the body part supporting the supporting member for movement relative to the housing. A folding axis defined in the folding area by the location of the hinge member is changeable in response to movement of the supporting member in the housing.

Abstract: The present invention relates to a novel promoter, a vector comprising the promoter, a microorganism comprising the promoter or the vector, and a method for producing a target product using the microorganism.

Abstract: The present invention relates to a composition for preventing, treating, or ameliorating muscle disease or regenerating damaged muscles, comprising squalene. More specifically, the squalene of the present invention increases expression of proteins which are associated with muscle protein synthesis and muscle mass increase in muscle cells, inhibits, at an mRNA level, expression of enzymes involved in muscle protein degradation, and has an effect of rapidly restoring damaged muscles. In addition, the present invention relating to a natural product can be safely used without side effects, and thus can be used as medicines, foods, or cosmetics.

Abstract: A method for producing high purity D-psicose crystals having a purity of 98% (w/w) or more and a grain size of MA200 or more. The method includes: removing impurities from a D-psicose solution to obtain a purified D-psicose solution; concentrating the purified D-psicose solution; cooling the concentrated D-psicose solution to 30° C. to 40° C. through a heat exchanger; seed crystallizing the D-psicose solution at 30° C. to 40° C. to obtain a seed crystallized massecuite; and full-scale crystallizing the seed crystallized massecuite. The method can produce pure D-psicose crystals in a suitable form for industrial application through an economical crystallization process from the D-psicose solution without using organic solvents.

Abstract: Unique epoxyketone compounds useful for inhibiting a proteasome in a cell, pharmaceutical compositions and methods of their use are provided herein.

Abstract: An orthogonal frequency division multiplexing (OFDM) transmission device transmits OFDM symbols to at least one reception device and includes an OFDM transmission processing unit which generates a plurality of OFDM symbols; a pilot insertion unit which inserts pilot tones into each of the plurality of OFDM symbols; and a control unit which controls the pilot insertion unit to insert the pilot tones according to a pilot insertion pattern which is selected to correspond to a communication environment from among a plurality of pilot insertion patterns.

Abstract: Vigna angularis var. angularis according to the present invention is capable of increasing muscle mass and enhancing muscular function or exercise performance through an effect of promoting mRNA or protein expression and the activity of a gene involved in muscle functions, muscle mass increase of differentiation of muscle cells; can prevent, treat or ameliorate a decline in exercise performance, a decline in muscle function, muscle loss, etc. caused by various diseases; and may be effectively used for medicines or food products, etc., since it has no side effects in the body as natural substance.